🇺🇸 FDA
Patent

US 10729668

Ketobutyrate compounds and compositions for treating age-related symptoms and diseases

granted A61KA61K31/19A61P

Quick answer

US patent 10729668 (Ketobutyrate compounds and compositions for treating age-related symptoms and diseases) held by The Regents of the University of California expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/19, A61P, A61P17/14, A61P25/28